{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:26:07Z","timestamp":1762521967950},"reference-count":79,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.semnephrol.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T06:30:57Z","timestamp":1477031457000},"page":"386-396","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatitis Viruses in Kidney Transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Kiran","family":"Gajurel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack T.","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.05.015_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12029","article-title":"A pathogenic picornavirus acquires an envelope by hijacking cellular membranes","volume":"496","author":"Feng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: a review and proposed re-classification as pegiviruses","volume":"92","author":"Stapleton","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.510240103","article-title":"Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction","volume":"24","author":"Yotsuyanagi","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/338152","article-title":"Influence of human immunodeficiency virus type 1 on acute hepatitis A virus infection","volume":"34","author":"Setsuko","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/hep.21439","article-title":"for the U.S. Acute Liver Failure Study Group). Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes","volume":"44","author":"Taylor","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib6","first-page":"611","article-title":"Clinical features of acute renal failure associated with hepatitis A virus infection","volume":"17","author":"Jung","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajt.12108","article-title":"and the AST Infectious Diseases Community of Practice. Viral hepatitis in solid organ transplantation","volume":"13","author":"Levitsky","year":"2013","journal-title":"J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib8","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the advisory committee on immunization practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib9","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1572-0241.1999.01150.x","article-title":"Immunogenicity of hepatitis A vaccine in decompensated liver disease","volume":"94","author":"Dumot","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/lt.500060216","article-title":"Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation","volume":"6","author":"Arslan","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib12","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.3748\/wjg.v16.i31.3878","article-title":"Hepatitis B virus infection and renal transplantation","volume":"16","author":"Tsai","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4254\/wjh.v7.i2.189","article-title":"Antiviral treatment for chronic hepatitis B in renal transplant patients","volume":"7","author":"Ridruejo","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007890-200201150-00016","article-title":"Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999","volume":"73","author":"Fong","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib15","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.transproceed.2005.06.068","article-title":"Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients","volume":"37","author":"Veroux","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.tp.0000189930.89031.1b","article-title":"Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study","volume":"81","author":"De Feo","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.tp.0000198585.51562.57","article-title":"Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients","volume":"81","author":"Fytili","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transproceed.2010.09.094","article-title":"Donors positive for hepatitis B core antibodies in nonliver transplantations","volume":"43","author":"Salvadori","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.transproceed.2011.01.155","article-title":"Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin","volume":"43","author":"Veroux","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1399-3062.2012.00782.x","article-title":"Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature","volume":"14","author":"Mahboobi","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib21","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.transproceed.2014.06.067","article-title":"Safety of kidney transplantation using anti-HBc-positive donors","volume":"46","author":"Abrao","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.transproceed.2004.05.014","article-title":"Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment","volume":"36","author":"Kim","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.transproceed.2005.06.011","article-title":"Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings","volume":"37","author":"Veroux","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/tid.12482","article-title":"Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(\u2212) donors","volume":"18","author":"Yilmaz","year":"2016","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib26","first-page":"1518","article-title":"Kidney transplantation from hepatitis B surface antigen (HBsAg)-positive donors: changes of relative HBV genomic copy number after transplantation","volume":"28","author":"Lai","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.transproceed.2008.09.056","article-title":"Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors","volume":"41","author":"Sumethkul","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.12659\/AOT.894073","article-title":"Assessment of long-term outcomes in Hbs Ag-negative renal transplant recipients transplanted from Hbs Ag-positive donors","volume":"20","author":"Yilmaz","year":"2015","journal-title":"Ann Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib29","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/ajt.12921","article-title":"The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study","volume":"14","author":"Chancharoenthana","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2015.04.011","article-title":"Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation","volume":"68","author":"Moal","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jvh.12184","article-title":"Hepatitis B and survival after renal transplant: meta-analysis of observational studies","volume":"21","author":"Fabrizi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib32","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jmv.20980","article-title":"Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen","volume":"79","author":"Ahn","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0b013e3181e5b811","article-title":"Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments","volume":"90","author":"Yap","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib34","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2215\/CJN.09201010","article-title":"Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States","volume":"6","author":"Reddy","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/jhep.2002.36156","article-title":"Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients","volume":"36","author":"Chan","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.transproceed.2013.01.088","article-title":"Comparison of clinical outcomes in hepatitis B virus-positive kidney transplant recipients with or without pretransplantation antiviral therapy","volume":"45","author":"Kim","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib37","first-page":"35","article-title":"Effect of prophylactic versus preemptive lamivudine treatment and tenofovir on HBsAg+ kidney transplant recipients","volume":"13","author":"Ruhi","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib38","first-page":"295","article-title":"Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection. Transplant","volume":"16","author":"Cho","year":"2014","journal-title":"Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneph.2014.122","article-title":"Immunization after kidney transplantation-what is necessary and what is safe?","volume":"10","author":"Kotton","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib40","first-page":"14","article-title":"A novel T cell evasion mechanism in persistent RNA virus infection. Trans","volume":"125","author":"Stapleton","year":"2014","journal-title":"Am Clin Climatol Assn"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 66 subtypes, updated criteria and assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.transproceed.2008.03.031","article-title":"Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data","volume":"40","author":"Kliem","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","article-title":"Hepatitis C and renal disease: an update","volume":"42","author":"Meyers","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib44","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv","volume":"3","author":"Cacoub","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/JCM.02407-15","article-title":"Role of serologic and molecular diagnostic assays in identification and management of hepatitis C virus infection","volume":"54","author":"Cloherty","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/511038","article-title":"Factors associated with seronegative chronic hepatitis C virus infection in HIV-infection","volume":"44","author":"Chamie","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib47","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MOT.0b013e32835a2bac","article-title":"Hepatitis C and renal transplantation","volume":"17","author":"Morales","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncpneph0953","article-title":"Kidney disease improving global outcomes. KDIGO clinical practice guidelines on hepatitis C in chronic kidney disease acknowledged by ISN","volume":"4","author":"Abboud","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib49","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1600-6143.2005.00864.x","article-title":"Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2013.06.024","article-title":"Direct-acting antiviral agents and the path to interferon independence","volume":"12","author":"Schmidt","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.05.015_bib51","first-page":"37","article-title":"Hepatitis delta virus: molecular biology, pathogenesis and immunology","volume":"3","author":"Casey","year":"1998","journal-title":"Antivir Ther"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0891-5520(20)30129-X","article-title":"Delta agent hepatitis","volume":"1","author":"Chatzinoff","year":"1987","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/653943","article-title":"The two faces of hepatitis E virus","volume":"51","author":"Teshale","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib55","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/jvh.12027","article-title":"Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area","volume":"20","author":"Naik","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib56","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/655898","article-title":"Pig liver sausage as a source of hepatitis E virus transmission to humans","volume":"202","author":"Colson","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib57","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/655899","article-title":"Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France","volume":"202","author":"Legrand-Abravanel","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1872-034X.2007.00024.x","article-title":"Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma","volume":"37","author":"Tamura","year":"2007","journal-title":"Hepatology Res"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib60","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/L15-0502","article-title":"Transmission of hepatitis E virus by plasma exchange: a case report","volume":"164","author":"Mallet","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib62","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.27219","article-title":"Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey","volume":"60","author":"Ditah","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib63","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/JCM.03624-14","article-title":"Systematic serological testing for hepatitis E virus in kidney transplant recipients","volume":"53","author":"Moal","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib64","first-page":"3","article-title":"Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center","author":"Sue","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3201\/eid1701.100527","article-title":"Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France","volume":"17","author":"Legrand-Abravanel","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1600-6143.2011.03838.x","article-title":"No reactivation of hepatitis e virus after kidney retransplantation","volume":"12","author":"Kamar","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib67","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiu032","article-title":"Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections","volume":"209","author":"Abravanel","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib68","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib69","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jmv.23469","article-title":"Infection with hepatitis E virus in kidney transplant recipients in southeastern France","volume":"85","author":"Moal","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib70","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib71","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jmv.23915","article-title":"Past and current hepatitis E virus infection in renal transplant patients","volume":"86","author":"Hering","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib72","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib73","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/TP.0000000000000850","article-title":"An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients","volume":"99","author":"Kamar","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib74","first-page":"261","article-title":"Chronic hepatitis E after solid organ transplantation","volume":"70","author":"de Niet","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/jvh.12403","article-title":"Antiviral therapy in chronic hepatitis E: a systematic review","volume":"22","author":"Peters van Ton","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tim.2012.01.004","article-title":"GB virus C: the good boy virus?","volume":"20","author":"Bhattarai","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2893.2009.01194.x","article-title":"GB virus type C interactions with HIV: the role of envelope glycoproteins","volume":"16","author":"Mohr","year":"2009","journal-title":"J Viral Hep"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib78","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/JVI.02752-14","article-title":"GB virus C coinfections in west African Ebola patients","volume":"89","author":"Lauck","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2016.05.015_bib79","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-14-0209","article-title":"GBV-C infection and risk of NHL among U.S. adults","volume":"74","author":"Chang","year":"2014","journal-title":"Cancer Res"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:28:15Z","timestamp":1657492095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516300468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0270929516300468"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.015","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis Viruses in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}